Previous 10 | Next 10 |
By Vinay Thapar The healthcare sector has been a reliable safe haven during even the most challenging markets. But the novel coronavirus panic is raising questions about its resilience. By looking beyond the pandemic at changes sweeping the industry, investors can find defensive healthcare...
The global response to the spread of COVID-19 has sparked an unprecedented decline in economic activity, and no industry is immune. However, the healthcare industry appears far more protected than most other sectors from coronavirus-related economic disruption. A Spectrum of Impact The h...
Despite the coronavirus concerns that have hit commodity markets and, in turn, energy and basic materials stocks, U.S. tech stocks have posted strong returns to start the year. This continues their impressive streak from 2019. But are the current tech valuations sustainable? In a recent mark...
By Vinay Thapar and Frank Caruso US healthcare is always a political hot potato, and volatility is expected to rise as the November elections approach. But investors can find good opportunities in the sector in companies with strong long-term business drivers that are relatively immune to ...
By Michelle Borré, CFA, Head of Fundamental Alternative Strategies , and Brian Giesen, CFA, Intermediate Research Analyst Restrictions on the pricing of drugs delivered in doctors' offices and hospitals could have significant investment implications. The Trump Administration is...
The presidential election year has begun, and the rhetoric around healthcare policy is likely to get louder as campaigning heats up. Tony DeSpirito talks with Portfolio Manager Erin Xie about the implications for health care stocks. In a year-end poll of our Fundamental Active Equity inves...
By Stephen H. Dover, CFA, Executive Vice President, Head of Equities, Krzysztof Musialik, CFA, Research Analyst, Franklin Templeton Emerging Markets Equity, and Steve Kornfeld, CFA, Portfolio Manager, Research Analyst, Franklin Equity Group The biopharma industry has the potential to save...
By Andy Acker, CFA & Luyi Guo, Ph.D., CFA & Rich Carney, CFA Last week, the Trump administration abandoned plans to overhaul drug rebates in Medicare while a federal judge ruled against listing prescription drug prices in TV ads. But U.S. drug reform is far from over, with implica...
By Stephen H. Dover, Executive Vice President, Head of Equities; Aman Gupta, Portfolio Manager, Research Analyst, Franklin Mutual Series; Brian DeChristopher, Research Analyst, Franklin Equity Group; Evan McCulloch, Portfolio Manager, Director of Equity Research, Franklin Equity Group; Krzysz...
President Trump will issue an executive order on Monday related to healthcare price transparency, according to WSJ sources . More news on: Health Care Select Sect SPDR ETF, Vanguard Health Care ETF, iShares U.S. Healthcare ETF, Healthcare stocks news, News on ETFs Read more ...
News, Short Squeeze, Breakout and More Instantly...
ProShares UltraShort Health Care Company Name:
RXD Stock Symbol:
NYSE Market:
2024-04-17 02:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-08 16:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-02-23 06:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...